The same global food system that is fueling rising obesity rates is also accelerating climate change, according to a sweeping ...

Wegovy maker Novo Nordisk filed for U.S. FDA approval of CagriSema, a once-weekly shot that combines two compounds to treat ...

CNBC's Annika Kim Constantino reports on Eli Lilly after the company said its closely watched obesity pill helped patients ...

The increase in high cholesterol and obesity cases has put nutrition research on the path of looking for culturally familiar ...

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

The number of US adults living with heart failure has more than doubled over the past three decades, mostly due to the rising ...

Although the injectable forms of the popular GLP-1 drugs are more effective, the pills under development are both easier to ...

Eli Lilly has now submitted a new drug application (NDA) for GLP-1RA orforglipron to the FDA for use in adults with obesity.

The new World Health Organization guideline supports using GLP-1 drugs for long-term obesity care, emphasizing lifestyle, ...

The filing comes as Novo fights tooth-and-nail with rival Lilly to regain its footing at the top of the weight loss market.

Healthy snacks are in demand as meals are being “swapped for grazing” as the rise of weight-loss jabs encourages a “change in ...

Informing patients about bariatric surgery is a comprehensive discussion, so aim to provide the most up-to-date information about both pre- and post-surgery expectations.